Logo image of ENX.PA

EURONEXT NV (ENX.PA) Stock Fundamental Analysis

EPA:ENX - Euronext Paris - Matif - NL0006294274 - Common Stock - Currency: EUR

144.1  -1.3 (-0.89%)

Fundamental Rating

5

ENX gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 112 industry peers in the Capital Markets industry. While ENX belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. ENX is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

ENX had positive earnings in the past year.
ENX had a positive operating cash flow in the past year.
In the past 5 years ENX has always been profitable.
ENX had a positive operating cash flow in each of the past 5 years.
ENX.PA Yearly Net Income VS EBIT VS OCF VS FCFENX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

1.2 Ratios

Looking at the Return On Assets, with a value of 0.35%, ENX is in line with its industry, outperforming 41.96% of the companies in the same industry.
ENX has a better Return On Equity (23.01%) than 86.61% of its industry peers.
ENX's Return On Invested Capital of 13.31% is amongst the best of the industry. ENX outperforms 91.07% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ENX is in line with the industry average of 8.47%.
The 3 year average ROIC (6.82%) for ENX is below the current ROIC(13.31%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.35%
ROE 23.01%
ROIC 13.31%
ROA(3y)0.24%
ROA(5y)2.39%
ROE(3y)12.67%
ROE(5y)15.83%
ROIC(3y)6.82%
ROIC(5y)8.05%
ENX.PA Yearly ROA, ROE, ROICENX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

ENX has a Profit Margin of 37.70%. This is amongst the best in the industry. ENX outperforms 80.36% of its industry peers.
In the last couple of years the Profit Margin of ENX has grown nicely.
ENX's Operating Margin of 51.60% is amongst the best of the industry. ENX outperforms 87.50% of its industry peers.
ENX's Operating Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 51.6%
PM (TTM) 37.7%
GM N/A
OM growth 3Y1.34%
OM growth 5Y-0.82%
PM growth 3Y4.18%
PM growth 5Y1.95%
GM growth 3YN/A
GM growth 5YN/A
ENX.PA Yearly Profit, Operating, Gross MarginsENX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

5

2. Health

2.1 Basic Checks

ENX has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, ENX has more shares outstanding
ENX has a better debt/assets ratio than last year.
ENX.PA Yearly Shares OutstandingENX.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ENX.PA Yearly Total Debt VS Total AssetsENX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B 250B

2.2 Solvency

ENX has an Altman-Z score of 0.07. This is a bad value and indicates that ENX is not financially healthy and even has some risk of bankruptcy.
ENX has a Altman-Z score (0.07) which is comparable to the rest of the industry.
ENX has a debt to FCF ratio of 5.20. This is a neutral value as ENX would need 5.20 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 5.20, ENX is doing good in the industry, outperforming 69.64% of the companies in the same industry.
ENX has a Debt/Equity ratio of 0.61. This is a neutral value indicating ENX is somewhat dependend on debt financing.
ENX has a Debt to Equity ratio of 0.61. This is comparable to the rest of the industry: ENX outperforms 56.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 5.2
Altman-Z 0.07
ROIC/WACCN/A
WACCN/A
ENX.PA Yearly LT Debt VS Equity VS FCFENX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

ENX has a Current Ratio of 1.00. This is a normal value and indicates that ENX is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.00, ENX is doing good in the industry, outperforming 64.29% of the companies in the same industry.
A Quick Ratio of 1.00 indicates that ENX should not have too much problems paying its short term obligations.
ENX has a better Quick ratio (1.00) than 64.29% of its industry peers.
Industry RankSector Rank
Current Ratio 1
Quick Ratio 1
ENX.PA Yearly Current Assets VS Current LiabilitesENX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B 250B

4

3. Growth

3.1 Past

ENX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.14%, which is quite impressive.
ENX shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 17.67% yearly.
The Revenue for ENX has decreased by -15.09% in the past year. This is quite bad
Measured over the past years, ENX shows a quite strong growth in Revenue. The Revenue has been growing by 19.09% on average per year.
EPS 1Y (TTM)21.14%
EPS 3Y7.11%
EPS 5Y17.67%
EPS Q2Q%27.04%
Revenue 1Y (TTM)-15.09%
Revenue growth 3Y7.8%
Revenue growth 5Y19.09%
Sales Q2Q%12.81%

3.2 Future

Based on estimates for the next years, ENX will show a small growth in Earnings Per Share. The EPS will grow by 2.56% on average per year.
Based on estimates for the next years, ENX will show a small growth in Revenue. The Revenue will grow by 4.33% on average per year.
EPS Next Y6%
EPS Next 2Y5.61%
EPS Next 3Y6.31%
EPS Next 5Y2.56%
Revenue Next Year11.07%
Revenue Next 2Y8.17%
Revenue Next 3Y7.23%
Revenue Next 5Y4.33%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ENX.PA Yearly Revenue VS EstimatesENX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B
ENX.PA Yearly EPS VS EstimatesENX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 19.96, the valuation of ENX can be described as rather expensive.
Compared to the rest of the industry, the Price/Earnings ratio of ENX indicates a somewhat cheap valuation: ENX is cheaper than 63.39% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of ENX to the average of the S&P500 Index (26.76), we can say ENX is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 19.66, the valuation of ENX can be described as rather expensive.
ENX's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ENX is cheaper than 66.96% of the companies in the same industry.
ENX's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 34.91.
Industry RankSector Rank
PE 19.96
Fwd PE 19.66
ENX.PA Price Earnings VS Forward Price EarningsENX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

78.57% of the companies in the same industry are more expensive than ENX, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, ENX is valued a bit cheaper than 72.32% of the companies in the same industry.
Industry RankSector Rank
P/FCF 25.08
EV/EBITDA 10.76
ENX.PA Per share dataENX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
ENX has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)3.33
PEG (5Y)1.13
EPS Next 2Y5.61%
EPS Next 3Y6.31%

4

5. Dividend

5.1 Amount

ENX has a Yearly Dividend Yield of 2.04%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 5.57, ENX has a dividend in line with its industry peers.
ENX's Dividend Yield is comparable with the S&P500 average which is at 2.36.
Industry RankSector Rank
Dividend Yield 2.04%

5.2 History

The dividend of ENX is nicely growing with an annual growth rate of 11.82%!
Dividend Growth(5Y)11.82%
Div Incr Years4
Div Non Decr Years4
ENX.PA Yearly Dividends per shareENX.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

30.03% of the earnings are spent on dividend by ENX. This is a low number and sustainable payout ratio.
The dividend of ENX is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP30.03%
EPS Next 2Y5.61%
EPS Next 3Y6.31%
ENX.PA Yearly Income VS Free CF VS DividendENX.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
ENX.PA Dividend Payout.ENX.PA Dividend Payout, showing the Payout Ratio.ENX.PA Dividend Payout.PayoutRetained Earnings

EURONEXT NV

EPA:ENX (8/21/2025, 7:00:00 PM)

144.1

-1.3 (-0.89%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)07-31 2025-07-31/amc
Earnings (Next)11-06 2025-11-06
Inst Owners52.44%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap15.02B
Analysts74.55
Price Target154.98 (7.55%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.04%
Yearly Dividend2.46
Dividend Growth(5Y)11.82%
DP30.03%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.03%
Min EPS beat(2)1.27%
Max EPS beat(2)4.79%
EPS beat(4)4
Avg EPS beat(4)4.32%
Min EPS beat(4)1.27%
Max EPS beat(4)6.1%
EPS beat(8)8
Avg EPS beat(8)5.32%
EPS beat(12)11
Avg EPS beat(12)5.55%
EPS beat(16)14
Avg EPS beat(16)5.25%
Revenue beat(2)2
Avg Revenue beat(2)0.5%
Min Revenue beat(2)0.31%
Max Revenue beat(2)0.69%
Revenue beat(4)3
Avg Revenue beat(4)0.16%
Min Revenue beat(4)-1.41%
Max Revenue beat(4)1.05%
Revenue beat(8)5
Avg Revenue beat(8)0.03%
Revenue beat(12)7
Avg Revenue beat(12)6.46%
Revenue beat(16)10
Avg Revenue beat(16)17.34%
PT rev (1m)1.42%
PT rev (3m)14.22%
EPS NQ rev (1m)-3.12%
EPS NQ rev (3m)-1.52%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0.59%
Revenue NQ rev (3m)7.82%
Revenue NY rev (1m)3.01%
Revenue NY rev (3m)3.01%
Valuation
Industry RankSector Rank
PE 19.96
Fwd PE 19.66
P/S 5.8
P/FCF 25.08
P/OCF 20.35
P/B 3.54
P/tB N/A
EV/EBITDA 10.76
EPS(TTM)7.22
EY5.01%
EPS(NY)7.33
Fwd EY5.09%
FCF(TTM)5.75
FCFY3.99%
OCF(TTM)7.08
OCFY4.91%
SpS24.86
BVpS40.73
TBVpS-17.76
PEG (NY)3.33
PEG (5Y)1.13
Profitability
Industry RankSector Rank
ROA 0.35%
ROE 23.01%
ROCE 17.66%
ROIC 13.31%
ROICexc 17.27%
ROICexgc N/A
OM 51.6%
PM (TTM) 37.7%
GM N/A
FCFM 23.12%
ROA(3y)0.24%
ROA(5y)2.39%
ROE(3y)12.67%
ROE(5y)15.83%
ROIC(3y)6.82%
ROIC(5y)8.05%
ROICexc(3y)8.95%
ROICexc(5y)12.69%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)9.05%
ROCE(5y)10.68%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y9.06%
ROICexc growth 5Y-11.21%
OM growth 3Y1.34%
OM growth 5Y-0.82%
PM growth 3Y4.18%
PM growth 5Y1.95%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 5.2
Debt/EBITDA 1.69
Cap/Depr 71.93%
Cap/Sales 5.37%
Interest Coverage 43.15
Cash Conversion 48.23%
Profit Quality 61.31%
Current Ratio 1
Quick Ratio 1
Altman-Z 0.07
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)56.3%
Cap/Depr(5y)51.18%
Cap/Sales(3y)6.45%
Cap/Sales(5y)5.35%
Profit Quality(3y)121.66%
Profit Quality(5y)112.44%
High Growth Momentum
Growth
EPS 1Y (TTM)21.14%
EPS 3Y7.11%
EPS 5Y17.67%
EPS Q2Q%27.04%
EPS Next Y6%
EPS Next 2Y5.61%
EPS Next 3Y6.31%
EPS Next 5Y2.56%
Revenue 1Y (TTM)-15.09%
Revenue growth 3Y7.8%
Revenue growth 5Y19.09%
Sales Q2Q%12.81%
Revenue Next Year11.07%
Revenue Next 2Y8.17%
Revenue Next 3Y7.23%
Revenue Next 5Y4.33%
EBIT growth 1Y-4.2%
EBIT growth 3Y9.25%
EBIT growth 5Y18.11%
EBIT Next Year25.83%
EBIT Next 3Y11.99%
EBIT Next 5Y7.06%
FCF growth 1Y14.67%
FCF growth 3Y9.28%
FCF growth 5Y22.23%
OCF growth 1Y17.49%
OCF growth 3Y9.23%
OCF growth 5Y22.8%